Literature DB >> 8426469

Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.

R Garand1, S Voisin, S Papin, V Praloran, B Lenormand, M Favre, P Philip, M Bernier, D Vanhaecke, A Falkenrodt.   

Abstract

A group of 30 acute lymphoblastic leukemias (ALL) with the early pro-T phenotype CD7+/cCD3+/CD1-/CD3-/CD4-/CD8-were identified among 103 newly diagnosed ALL with T-lineage markers (T-ALL). Pro T-ALL was more often observed in adults, and showed a lower incidence of hyperleukocytosis than more mature T-ALL. Mediastinal masses and polar acid phosphatase positivity in blast cells were however observed with the same frequency in pro T-ALL and late T-ALL, and rearrangements of both T-cell receptor (TCR) beta and gamma genes were observed in half the pro T-ALL cases tested. The expression of CD34, DR, and myeloid (My) markers was significantly more frequent in pro T-ALL than in late T-ALL, and these three features were strongly linked. TCR gene rearrangements were two to three times more frequent in CD34- and My-pro T-ALL. However, both CD34+ and My+ pro T-ALL showed an incidence of mediastinal masses and polar acid phosphatase positivity similar to this observed in CD34- and My- cases. This supports the assumption that both types of ALL indeed are engaged in the T-lineage, and confirms intracytoplasmic cCD3 as the earliest marker for this lineage. Moreover, CD34 appears to persist up to an early stage of T-cell maturation, where the cells retain myeloid potentiality. Loss of CD34 correlates with TCR-beta gene rearrangement and definitive commitment to the T lineage. Event-free survival analysis suggested a poorer outcome for pro T-ALL in adult patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426469

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  5 in total

Review 1.  Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.

Authors:  Adele K Fielding; Lalita Banerjee; David I Marks
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

2.  Adult T Lymphoblastic Leukemia (Pro-T ALL) with Reactive Monocytosis: A Case Report.

Authors:  Rachna Khera; Parul Gautam; Sanjeev Gupta; Prerna Arora; Tejinder Singh; Naresh Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2012-08-21       Impact factor: 0.900

3.  Chronic prolymphocytoid leukaemia with an unusual immature immunophenotype.

Authors:  M Lima; J Coutinho; A Orfão; A L Macedo; J F San Miguel; B Justiça
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

4.  Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.

Authors:  Linda Zuurbier; Alejandro Gutierrez; Charles G Mullighan; Kirsten Canté-Barrett; A Olivier Gevaert; Johan de Rooi; Yunlei Li; Willem K Smits; Jessica G C A M Buijs-Gladdines; Edwin Sonneveld; A Thomas Look; Martin Horstmann; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

Review 5.  Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets.

Authors:  Eulàlia Genescà; Roberta la Starza
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.